PJ Online | News: Cataract risk with inhaled steroids
Cataract risk with inhaled steroids
The increased risk of cataract associated with systemic corticosteroid use is also seen with inhaled therapy.
A study of more than 30,000 people found that those with cataracts were more likely to have been treated with inhaled steroids than those who did not have cataracts. For people prescribed corticosteroids at daily doses of 1,600mg or more, 41 per cent of their cataract risk was calculated to be due to their inhaled steroids (British Journal of Ophthalmology ).
Citation: Electronicjuice URI: 20010281
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.